Postpartum complete atrioventricular block due to cardiac Sarcoidosis: Steroid therapy without permanent pacemaker

International Heart Journal

Volumn 49, Issue 3, 2008, Pages 377-384

  Sugishita, Kazuro ^a   Togashi, Yuki ^a   Aizawa, Akira ^a,b   Asakawa, Masako ^a   Usui, Shin Ichi ^a   Ito, Nobuhiko ^a,c   Yamaguchi, Tetsuo ^a   Hada, Yoshiyuki ^a,d   Takahashi, Toshiyuki ^a  

^a JR Tokyo General Hospital   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c The Mutualaid Association of Public School Teachers)   (Japan)

^d Sakakibara Memorial Hospital   (Japan)

Author keywords

Cardiac sarcoidosis; Complete atrioventricular block; Delivery; Steroid therapy

Indexed keywords

DIPYRIDAMOLE; PREDNISOLONE; TECHNETIUM 99M;

ADULT; ARTICLE; CASE REPORT; COMPLETE HEART BLOCK; COMPUTER ASSISTED TOMOGRAPHY; DELIVERY; DRUG DOSE REDUCTION; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART PACING; HEART SCINTISCANNING; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHADENOPATHY; PRIORITY JOURNAL; PUERPERIUM; SARCOIDOSIS; SYNCOPE; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHIES; FEMALE; GLUCOCORTICOIDS; HUMANS; PACEMAKER, ARTIFICIAL; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SARCOIDOSIS;

EID: 49449103594     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.377     Document Type: Article

References (11)

1. Slatement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (SRS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
2. Matsui S, Yamashita N, Maruyama M, Kashii T, Taki H, Kobayashi M. Effects of pregnancy and delivery on sarcoidosis. Jap J Sarcoidosis Other Granulomatous Disorders 2001; 21: 25-9. (Japanese)
3. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278: 455-69.
4. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63: 86-108.
5. Fleming HA, Bailey SM. The prognosis of sarcoid heart disease in the United Kingdom. Ann NY Acad Sci 1986; 465: 543-50.
6. Seballos RJ, Mendel SG, Mirmiran-Yazdy A, Khoury W, Marshall JB. Sarcoid cardiomyopathy precipitated by pregnancy with cocaine complications. Chest 1994; 105: 303-5.
7. Reuhl J, Schneider M, Sievert H, Lutz FU, Zieger G. Myocardial sarcoidosis as a rare cause of sudden cardiac death. Forensic Sci Int 1997; 89: 145-53.
8. Sugisaki K, Yamaguchi T, Nagai S, et al. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 222-6.
9. Hiramitsu S, Morimoto S, Uemura A, et al. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 210-3.
10. Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidasis Vasc Diffuse Lung Dis 2003; 20: 133-7.
11. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with predonisone. Am J Cardiol 2001; 88: 1006-10.